bDMARDs-话题@MedSci

#bDMARDs#

1篇内容 | 1269人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2254031, encodeId=0694225403126, content=<a href='/topic/show?id=35791023eaf' target=_blank style='color:#2F92EE;'>#JAK抑制剂#</a> <a href='/topic/show?id=87293296e3' target=_blank style='color:#2F92EE;'>#bDMARDs#</a> <a href='/topic/show?id=95b7124e0393' target=_blank style='color:#2F92EE;'>#非系统性幼年特发性关节炎#</a>, objectTitle=ACR Open Rheumatol：JAK抑制剂与bDMARDs治疗非系统性幼年特发性关节炎的疗效和安全性, objectType=article, longId=864746, objectId=9c6f864e4688, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241211/1733884338561_8538692.png, objectUrl=/article/show_article.do?id=9c6f864e4688, replyNumber=0, likeNumber=0, createdTime=2025-02-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=9c6f864e4688, moduleTitle=ACR Open Rheumatol：JAK抑制剂与bDMARDs治疗非系统性幼年特发性关节炎的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c6f864e4688)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1242627, encodeId=617a124262e62, content=<a href='/topic/show?id=00664830602' target=_blank style='color:#2F92EE;'>#巴瑞替尼#</a>、<a href='/topic/show?id=d15b546e9f7' target=_blank style='color:#2F92EE;'>#托法替布#</a>与<a href='/topic/show?id=87293296e3' target=_blank style='color:#2F92EE;'>#bDMARDs#</a>治疗<a href='/topic/show?id=6d00e616523' target=_blank style='color:#2F92EE;'>#类风湿关节炎#</a>的疗效比较, objectTitle=Rheumatology：巴瑞替尼、托法替布与bDMARDS治疗类风湿关节炎的疗效比较, objectType=article, longId=299909, objectId=e2b12999097b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202232/1646188506704_5552845.jpg, objectUrl=/article/show_article.do?id=e2b12999097b, replyNumber=0, likeNumber=173, createdTime=2022-09-02, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2b12999097b, moduleTitle=Rheumatology：巴瑞替尼、托法替布与bDMARDS治疗类风湿关节炎的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2b12999097b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

bDMARDs

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#JAK抑制剂# #bDMARDs# #非系统性幼年特发性关节炎#

ACR Open Rheumatol：JAK抑制剂与bDMARDs治疗非系统性幼年特发性关节炎的疗效和安全性

2025-02-28发表于陕西省

循证小兵 (审核中...)

前往app查看评论内容

#巴瑞替尼#、#托法替布#与#bDMARDs#治疗#类风湿关节炎#的疗效比较

Rheumatology：巴瑞替尼、托法替布与bDMARDS治疗类风湿关节炎的疗效比较

2022-09-02

科室
- - 订阅+
  - 更多科室
工具
服务